What’s the appropriate dose for treating lung metastases from oligometastatic HNSCC with SBRT? Have a look at our TCP models in the Green Journal @estroradiotherapy.bsky.social! Thanks to all colleagues and collaborators! @ruehlealex.bsky.social www.thegreenjournal.com/article/S016...

Could radiation therapy reshape care for non-malignant CNS diseases? Read our latest work! @astro-org.bsky.social @estroradiotherapy.bsky.social @ruehlealex.bsky.social www.sciencedirect.com/science/arti...

How can radiation therapy for grade 2 meningiomas be improved, and what are the failure patterns? Read our new publication in @ijrobp.bsky.social! @astro-org.bsky.social @estroradiotherapy.bsky.social @neuroonc.bsky.social @eanoassociation.bsky.social www.redjournal.org/article/S036...

What’s the role of the extent of resection in grade 2 IDH-mutant glioma? I’m delighted to see this work published in @thelancetoncol.bsky.social — thanks and congratulations to the team! @neuroonc.bsky.social @eanoassociation.bsky.social www.thelancet.com/journals/lan...

Our new ESTRO CNS Focus Group analysis uncovers how reirradiation is used in primary brain tumors – read the full paper: www.thegreenjournal.com/article/S016... @estroradiotherapy.bsky.social @eanoassociation.bsky.social @astro-org.bsky.social @neuroonc.bsky.social @andradaturcas.bsky.social

Can DNA methylation risk groups unlock personalized radiotherapy decisions in meningioma? Our new paper provides the clinical framework — thanks to all collaborators! @neuroonc.bsky.social @eanoassociation.bsky.social @gelarehzadeh.bsky.social @icomeningioma.bsky.social doi.org/10.1093/neuo...

#EANO2025 comes to an end - it was a fantastic conference, thanks to everyone who participated and made it possible! See you next year in Rome! @eanoassociation.bsky.social @maxmastall.bsky.social @mj-mair.bsky.social @galldiks.bsky.social @profajchalmers.bsky.social

The final day of #EANO2025 starts with the general assembly! Wonderful to see how well each committee is doing, thank you very much! @eanoassociation.bsky.social @galldiks.bsky.social @mj-mair.bsky.social @maxmastall.bsky.social @profajchalmers.bsky.social @jmwerner.bsky.social

Lively debates and sharp arguments at the #EANO2025 Youngsters Pro&Con Session - informative, entertaining, and full of expert insights, this is what scientific exchange should look like! #NeuroOncology @eanoassociation.bsky.social @maxmastall.bsky.social @galldiks.bsky.social

We had a brilliant #EANO2025 Youngsters and CBI session with countless helpful tricks for young investigators! @eanoassociation.bsky.social @maxmastall.bsky.social @mj-mair.bsky.social @galldiks.bsky.social @profajchalmers.bsky.social

The second day of EANO 2025 in Prague begins – featuring a full schedule of high-level science, clinical innovation, and exchange across all disciplines in #NeuroOncology. See what’s on today 👉 eano.eu/eano2025/pro... #Immuntherapy #Gliom #Neurosurgery #Youngsters #Radiotherapy #FamilyFocusedCare

The next day of #EANO2025 starts with many valuable insights from the EANO Youngsters-EORTC session on clinical trials! @eanoassociation.bsky.social

Today‘s sessions on intraoperative diagnostics and radiation therapy for gliomas at #EANO2025 were highly informative! @eanoassociation.bsky.social @profajchalmers.bsky.social

The opening plenary session at #EANO2025 highlighted some of the considerable advances made in the field! @eanoassociation.bsky.social

Storytelling matters! We had a great session about the importance of storytelling in #NeuroOncology at #EANO2025 @eanoassociation.bsky.social @mj-mair.bsky.social @maxmastall.bsky.social @galldiks.bsky.social

Last night‘s #EANO2025 reception was a blast - lots of opportunities to connect and reconnect with so many great people in the field! @eanoassociation.bsky.social @mj-mair.bsky.social @mj-mair.bsky.social @profajchalmers.bsky.social @apellerino85.bsky.social @galldiks.bsky.social

#EANO2025 is starting off strong with the Educational Day, featuring the clinical, basic science, and supportive care tracks! #NeuroOncology @eanoassociation.bsky.social @maxmastall.bsky.social @jmwerner.bsky.social @profajchalmers.bsky.social @apellerino85.bsky.social @galldiks.bsky.social

👉 We are very proud to present our #EANO2025 ambassadors! Follow them on LinkedIn a/o Bluesky for a range of expert insights & join the conversation using the official hashtag #EANO2025. We look forward to meeting you all in #Prague! #NeuroOncology #btsm

Excited to share our latest @ijrobp.bsky.social paper on modeling brain necrosis progression based on vascular heterogeneity! Huge congrats to the team for this accomplishment! @astro-org.bsky.social @estroradiotherapy.bsky.social @eanoassociation.bsky.social www.redjournal.org/article/S036...

Had a fantastic time at #ASTRO2025 in San Francisco - grateful for the chance to reconnect with colleagues, collaborators, and friends from around the world! @astro-org.bsky.social @ucsfradonc.bsky.social @ruehlealex.bsky.social

Excited to share our latest work on TERT mutations in meningiomas, just published in @thelancetoncol.bsky.social! A huge thanks to the team! @neuroonc.bsky.social @eanoassociation.bsky.social @icomeningioma.bsky.social www.thelancet.com/journals/lan...

Treating adrenal gland metastases with SBRT? Check out our latest guide - huge thanks to all collaborators! @estroradiotherapy.bsky.social @astro-org.bsky.social www.practicalradonc.org/article/S187...

The extent of resection in brain metastases plays a critical role – but how impactful is it? Dive into our latest analysis, featuring data from 867 patients! journals.lww.com/neurosurgery...

What’s the role of radiosurgery in pediatric patients with CNS lesions? Here’s our first multicenter study! @estroradiotherapy.bsky.social www.thegreenjournal.com/article/S016...

Reirradiation with SRS for vestibular schwannomas – how effective and safe is it? Check out our latest systematic review & meta-analysis! @estroradiotherapy.bsky.social www.ctro.science/article/S240...

Just published: Our early experience with proton CSI for LMD from solid tumors in adults - now online! @eanoassociation.bsky.social @neuroonc.bsky.social doi.org/10.1186/s130...

@felixehretmd.bsky.social is a research fellow at MGH and @harvardmed.bsky.social, as well as a #RadiationOncology resident @ChariteBerlin. His research focuses on refining and personalizing radiation therapy for various #BrainTumors, including gliomas, brain metastases, and #meningiomas.

What do 1p losses and 1q gains mean for meningiomas? Read our latest study in JAMA Oncology! Huge thanks to everyone involved! @gelarehzadeh.bsky.social @icomeningioma.bsky.social jamanetwork.com/journals/jam...

As every year, the RSS annual meeting was a wonderful opportunity to connect with both old and new friends and collaborators!

The EORTC 2024 ROSC State of Science Report is out! Huge thanks to all co-authors and contributors for their excellent work! @eortc.bsky.social www.ejcancer.com/article/S095...

If you treat vestibular schwannomas with radiosurgery, this guide from The Radiosurgery Society is for you! Huge thanks to all collaborators! @eanoassociation.bsky.social @neuroonc.bsky.social @astro-org.bsky.social www.practicalradonc.org/article/S187...

Here’s our multicenter analysis on SBRT for pulmonary metastases in oligometastatic head and neck cancer patients - A great collaborative effort! www.redjournal.org/article/S036...